Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors
The EphA2 receptor tyrosine kinase is overexpressed in most solid tumors and acts as the major driver of tumorigenesis. In this study, we developed a novel approach for targeting the EphA2 receptor using a 2'-fluoro-modified pyrimidine RNA aptamer termed ATOP. We identified the ATOP EphA2 aptam...
Saved in:
Main Authors: | Laura Santana-Viera (Author), Justin P. Dassie (Author), Marta Rosàs-Lapeña (Author), Silvia Garcia-Monclús (Author), Mariona Chicón-Bosch (Author), Marina Pérez-Capó (Author), Lidia del Pozo (Author), Sara Sanchez-Serra (Author), Olga Almacellas-Rabaiget (Author), Susana Maqueda-Marcos (Author), Roser López-Alemany (Author), William H. Thiel (Author), Paloma H. Giangrande (Author), Oscar M. Tirado (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
by: Theodore J. Kottom, et al.
Published: (2024) -
Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
by: Ahmed F. Salem, et al.
Published: (2020) -
COMPLEMENTARY EXPRESSION OF EphA7 AND SCO-SPONDIN DURING POSTERIOR COMMISSURE DEVELOPMENT
by: Karen eStanic, et al.
Published: (2014) -
Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic
by: Walid Kamoun, et al.
Published: (2020) -
EphA2 is a biomarker of hMSCs derived from human placenta and umbilical cord
by: Shih-Pei Shen, et al.
Published: (2015)